Results 211 to 220 of about 11,518 (273)

Neuropsychiatric signs and symptoms of Alzheimer\u27s disease: New treatment paradigms [PDF]

, 2017
et al,, Musiek, Erik
core   +1 more source

Glymphatic Function in Prodromal Parkinson's Disease: Associations With Symptoms, Gray Matter Volume, and Phenoconversion Risk

European Journal of Neurology, Volume 32, Issue 10, October 2025.
ABSTRACT Background and Objectives Glymphatic dysfunction occurs in Parkinson's disease (PD), but its status in prodromal PD (pPD) is unclear. Using the diffusion tensor imaging along perivascular spaces (DTI‐ALPS) index as an indirect proxy, this study aims to evaluate glymphatic‐related changes in a pPD cohort and to explore their relationship with ...
Amei Chen, Zhanyu Kuang, Pek‐Lan Khong, Junxiang Huang, Jinyu Wen, Yoon Seong Choi, Yongzhou Xu, Peng Wu, Xinhua Wei   +8 more
wiley   +1 more source

Dexmedetomidine and the glymphatic system: a new perspective in managing postoperative cognitive dysfunction. [PDF]

Front Pharmacol
Zhang SS, Meng FG, Rong YY, Zhang YW, Liu HQ.   +4 more
europepmc   +1 more source

The Future of Non‐Invasive Brain Stimulation in Sleep Medicine

Journal of Sleep Research, Volume 34, Issue 5, October 2025.
ABSTRACT Non‐invasive brain stimulation (NIBS) methods carry particular appeal as non‐pharmacological approaches to inducing or improving sleep. However, intense research efforts to use transcranial magnetic stimulation (TMS) and electrical stimulation (tES) for sleep modulation have not yet delivered evidence‐based NIBS treatments in sleep medicine ...
Lukas B. Krone, Seo Ho Song, Valeria Jaramillo, Ines R. Violante   +3 more
wiley   +1 more source

Glymphatic System in Adolescents with Major Depressive Disorder: No Dysfunction and No Association with Poor Sleep Quality. [PDF]

Nat Sci Sleep
Zhang J, Zou X, Cai X, Zou M, Li H, Feng R.   +5 more
europepmc   +1 more source

Dreaming of Better Treatments: Advances in Drug Development for Sleep Medicine and Chronotherapy

Journal of Sleep Research, Volume 34, Issue 5, October 2025.
ABSTRACT Throughout history, the development of new sleep medicines has been driven by progress in our understanding of the mechanisms underlying sleep. Ancient civilisations used their understanding of the sedative nature of natural herbs and compounds to induce sleep.
Brooke A. Prakash, Ishani Shah, Guohao Ni, Sridhar Vasudevan, Aarti Jagannath, Russell G. Foster   +5 more
wiley   +1 more source

Intrahippocampally Injected Human Recombinant Clusterin Reduces Amyloid‐β Aggregate Size in Cerebral Arteriole Walls of Clusterin Knockout Mice

Neuropathology and Applied Neurobiology, Volume 51, Issue 5, October 2025.
This study examined how clusterin influences amyloid beta (Aβ) deposition in the brain's blood vessels using clusterin deficient mice. The presence of human recombinant CLU, introduced by intrahippocampal injection, reduced the size of Aβ deposits in arteriolar walls but did not affect overall Aβ levels. These results suggest CLU plays a direct role in
Alexandru Laslo, Tudor‐Gabriel Boghițoiu, Laura Chinezu, Doina Manu, Adrian Dumitru Ivanescu, Bogdan Andrei Cordoș, Mark R. Wilson, Claudia Banescu, John D. Fryer, Ajay Verma, Jennifer M. Dewing, Roxana‐Octavia Carare   +11 more
wiley   +1 more source

The glymphatic system as a therapeutic target: TMS-induced modulation in older adults. [PDF]

Front Aging Neurosci
Sundman MH, Liu Y, Chen NK, Chou YH.
europepmc   +1 more source

Circadian influences on central nervous system barriers and the glymphatic system. [PDF]

Front Physiol
Elliott BD, Kisamore CO, Nelson RJ, DeVries AC, Walker WH.   +4 more
europepmc   +1 more source

Glymphatic system dysfunction in chronic tinnitus patients with sleep disturbance. [PDF]

Front Neurol
Du Y, Huang Z, Xu JJ, Xue Y, Che Z.
europepmc   +1 more source